Acino is a global pharmaceutical company which develops, manufactures and markets well-proven, hard-to-develop products in novel drug delivery forms. The company is a leader in advanced drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals. Under the brand “Acino Switzerland”, Acino also markets a portfolio of Swiss-quality medicines in fast-growing emerging markets.
Headquarters: Zurich, Switzerland